Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study
2015 ◽
Vol 73
(2)
◽
pp. 331-333.e1
◽
Keyword(s):
2019 ◽
Vol 181
(6)
◽
pp. 1177-1189
◽
Keyword(s):
Keyword(s):
2002 ◽
Vol 146
(3)
◽
pp. 414-422
◽
2009 ◽
Vol 33
(8)
◽
pp. 857-865
◽
Keyword(s):
2019 ◽
Vol 46
(3)
◽
pp. 186-192
◽
Keyword(s):
Keyword(s):
2005 ◽
Vol 52
(3)
◽
pp. P173